Muhammad Alsabagh: Structured Clinical Algorithms for Pediatric and AYA Bone Marrow Failure Syndromes
Muhammad Alsabagh, Pediatric Oncology Assistant, Lecturer and Specialist at National Cancer Institute of Cairo University, Member of The EBMT, shared a post on LinkedIn:
“I’m pleased to share a set of practical clinical algorithms I’ve developed for the evaluation and management of pancytopenia and bone marrow failure in children and adolescents/young adults (AYA).
These visual algorithms aim to simplify complex decision-making in daily practice, covering:
- Diagnostic approach to persistent pancytopenia
- Differentiation between aplastic anemia, hypocellular MDS, and inherited bone marrow failure syndromes (IBMFS)
- Indications for germline genetic testing
- Decision-making for IST versus upfront HSCT
- Transplant timing across major IBMFS entities
The goal is to provide a structured, practical, and clinically applicable framework that can be used at the bedside or in multidisciplinary discussions.
I’ve compiled all algorithms into a single PDF for easy use and sharing.
I would truly value feedback, discussion, and insights from colleagues in hematology, oncology, and transplantation.”
Stay updated with Hemostasis Today.
-
May 13, 2026, 07:35Ifeanyichukwu Ifechidere: Why DIC is the Condition That Humbles even the Most Experienced Scientists
-
May 13, 2026, 07:26Genoveva Uzunova: Why It’s Time to Close the Sex Variable Gap in Healthcare
-
May 13, 2026, 07:09Auston Cherbonneaux: Why Erythritol Just Joined the High-Hazard List
-
May 13, 2026, 06:48Akshat Jain: Transforming Sickle Cell Care With Practical Apheresis Frameworks
-
May 13, 2026, 06:35Dima Shulkin: How Neutrophil Extracellular Traps Shape ACS
-
May 13, 2026, 05:50Danny Hsu: Global Maternal VTE Awareness and Opportunities for Prevention
-
May 13, 2026, 05:50Ney Carter Borges: Clinical Cardiovascular Polygenic Risk Report for 8 Conditions
-
May 13, 2026, 05:49Kalyan Roy: A New Blood Group System Has Been Discovered
-
May 13, 2026, 05:07Azin Alizadehasl: Unraveling DIC in Cancer-Driven Coagulopathy